Richard Hoefield
University of Salford
8 Papers
39 Citations
Richard Hoefield is an academic researcher from University of Salford. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 7, co-authored 8 publications. Previous affiliations of Richard Hoefield include University of Manchester.
Chat about Author
Papers
Serum Phosphate and Mortality in Patients with Chronic Kidney Disease
Helen Eddington,Richard Hoefield,Smeeta Sinha,Constantina Chrysochou,Beverley Lane,Robert N. Foley,Janet Hegarty,John P. New,Donal O'Donoghue,Rachel J. Middleton,Philip A. Kalra +10 more
TL;DR: As phosphate levels below published targets are associated with better survival, guidelines for phosphate in nondialysis CKD patients should be re-examined.
234
Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms
Ben Caplin,Ben Caplin,Dorothea Nitsch,Herpreet Gill,Richard Hoefield,Scott Blackwell,Douglas MacKenzie,Jackie A. Cooper,Rachel J. Middleton,Philippa J. Talmud,PS Veitch,Jill T. Norman,David C. Wheeler,James Leiper +13 more
TL;DR: It is concluded that polymorphisms in DDAH1 alter the rate of decline of glomerular filtration rate in subjects with chronic kidney disease, and modulates plasma asymmetric dimethylarginine and contributes to the decline in renal function.
34
Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects
Rebecca Brown,Ali Mohsen,Darren Green,Darren Green,Richard Hoefield,Richard Hoefield,Lucinda K. M. Summers,Lucinda K. M. Summers,Rachel J. Middleton,Rachel J. Middleton,Donal O'Donoghue,Donal O'Donoghue,Philip A. Kalra,Philip A. Kalra,David I. New,David I. New +15 more
TL;DR: Neither BMI as a continuous variable nor obesity (BMI≥30) as a categorical variable was associated with an increased rate of progression of existing CKD in this predominantly white population in Greater Manchester.
34
Renal disease is associated with accelerated vascular ageing: initial results of the uk research alliance into kidney disease and arterial stiffness (ureka) collaboration: 8a.02
Laurie A. Tomlinson,Yoav Ben-Shlomo,Ben Caplin,Christian Delles,Charles J. Ferro,Jane Goddard,Richard Hoefield,Stephen G Holt,Philip A. Kalra,Carmel M. McEniery,Christopher W. McIntyre,E. P. Mcquarrie,Chakravarthi Rajkumar,Tessa Savage,Maarten W. Taal,Charles R.V. Tomson,Jonathan N. Townend,David J. Webb,David C. Wheeler,I.B. Wilkinson +19 more
TL;DR: The presence of renal disease in the absence of other co-morbidities is associated with increased aPWV compared to controls, and degree of aortic stiffening is independently related to renal function.
8
Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Ali Mohsen,Rebecca Brown,Richard Hoefield,Philip A. Kalra,Donal O'Donoghue,Rachel J. Middleton,David I. New +6 more
TL;DR: Raised BMI did not influence the rate of progression of chronic kidney disease in patients with type 2 diabetes mellitus, and linear regression analysis showed no relationship between eGFR and BMI.